Sharon Adler, MD

Dr. Adler’s experimental and clinical research focuses on all aspects of diabetic kidney disease and glomerulonephritis. She recently discovered molecules in the urine that facilitate the identification of kidney disease early on; this discovery is expected to open up new avenues for the treatment of kidney disease and for the preservation of the peritoneal membrane. She is a member of two NIH-sponsored consortia to understand the pathogenesis of glomerular diseases in order to find new treatments based on a more sophisticated understanding of pathogenesis.

Dr. Sharon Adler is a nephrologist in Southern California. She is a Professor of Medicine at the Geffen School of Medicine at UCLA and an investigator at the Lundquist Research Institute at Harbor-UCLA Medical Center. As a site PI of the NIH-funded studies Nephrotic Syndrome Study Network (NEPTUNE) and CureGN, and the foundation-funded Kidney Research Network (KRN), she participates in the “team science” that is pushing glomerular disease discovery and translational science to the forefront of nephrology. These consortia are stimulating novel treatments based on –omics to guide precision medicine, laying the groundwork for focused strategies and the promise of remission and recovery. She is the founding editor-in-chief of an online, open-access first-in-class journal, Glomerular Diseases.